Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | DS-1471a |
| Synonyms | |
| Therapy Description |
DS-1471a is a monoclonal antibody targeting CD147, which potentially inhibits tumor growth (Mol Cancer Ther (2023) 22 (12_Supplement): B127; Mol Cancer Ther (2023) 22 (12_Supplement): A138). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| DS-1471a | DS 1471a|DS1471a | DS-1471a is a monoclonal antibody targeting CD147, which potentially inhibits tumor growth (Mol Cancer Ther (2023) 22 (12_Supplement): B127; Mol Cancer Ther (2023) 22 (12_Supplement): A138). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06074705 | Phase I | DS-1471a | A Study of DS-1471a In Subjects With Advanced Solid Tumors | Terminated | USA | 1 |